Samuraciclib hydrochloride (ICEC0942 hydrochloride) is a potent, selective, ATP competitive and oral active CDK7 inhibitor with IC50 of 41 nM. The selectivity of Samuraciclib hydrochloride is 45-, 15-, 230- and 30-fold higher than CDK1, CDK2 (IC50 is 578 nM), CDK5 and CDK9 respectively. Samuraciclib hydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 µM. Samuraciclib hydrochloride has anti-tumor effects.
Molecular Weight:
430.97
Purity:
0.998
CAS Number:
[1805789-54-1]
Formula:
C22H31ClN6O
Target:
Apoptosis|||CDK
T10898
* VAT and and shipping costs not included. Errors and price changes excepted
